Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > A little movement on a patent

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Jun 27, 2022 9:34am

189 Views

Post# 34784188

RE:RE:A little movement on a patent

Looks like Ruvacare, Theralase's anti-cancer vaccine.

FGPstock wrote:
Pandora, would this patent be for something different? "VACCINE CONTAINING CANCER CELLS INACTIVATED". I don't believe either the combs/covid research would fall under this category, nor would a typical TLD treatment be considered a vaccine.

Is this a new treatment to trigger an immune response/antibodies?

Pandora wrote:

16/610,991 VACCINE CONTAINING CANCER CELLS INACTIVATED BY PHOTODYNAMIC TREATMENT WITH METAL-BASED COORDINATION COMPLEXES, AND IMMUNOTHERAPY METHOD USING SAME T1081/20076

Transaction History

Date Transaction Description

06-24-2022 Notice of Allowance Data Verification Completed